Patent row between pharma companies referred to European court

  • 📰 IrishTimesBiz
  • ⏱ Reading Time:
  • 23 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 13%
  • Publisher: 77%

Nigeria News News

Nigeria Nigeria Latest News,Nigeria Nigeria Headlines

Clonmel and Merck in dispute over combination of ingredients in cholesterol drug via IrishTimesBiz

It began when MSD sued Clonmel claiming the defendant was breaching its 2005 supplementary protection certificate , and extended patent protection, governing MSD’s authorisation for its drug “Inegy”.

MSD disputed Clonmel’s claims. It said once the combination has been the subject of a specific claim in patent, this was a complete answer to Clonmel’s case. However, the High Court rejected a third claim by Clonmel that the SPC was invalid because the marketing authorisation for the combination was not the first marketing authorisation for such combination and the SPC was granted contrary to the provisions of Article 3 of the regulation.

We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

 /  🏆 6. in NG
 

Thank you for your comment. Your comment will be published after being reviewed.
Please try again later.

Nigeria Nigeria Latest News, Nigeria Nigeria Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

Conor Murray and Rory McIlroy help Whoop get on track for Irish marketing campaign | Business PostConor Murray and Rory McIlroy help Whoop get on track for Irish marketing campaign – emmetjryan reports. emmetjryan They'd want to get the orders right. Waiting 8 weeks for a band and no idea of when I will receive it
Source: businessposthq - 🏆 8. / 71 Read more »